Larvol Delta - A-Phase-I-OpenLabel-Dose-Escalation-and-Cohort-Expansion-Study-of-BS-HH-002SA-in-Patients-With-AML-and-MDS

homoharringtonine derivative (BS-HH-002.SA) - Bensheng Pharma

http://clinicaltrials.gov/ct2/show/NCT04743115

Feb 8, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev